Likely - I don't think MXR has another other clients for the mill at present? ERL finished last year, and MXR's response to the ASX on Tuesday (26/03) only references GBF with respect to toll treatment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025